Skip to main content

Trelegy Ellipta Prices, Coupons, Copay Cards & Patient Assistance

Trelegy Ellipta (fluticasone/umeclidinium/vilanterol) is a member of the bronchodilator combinations drug class and is commonly used for Asthma, and COPD.

The cost for Trelegy Ellipta (100 mcg-62.5 mcg-25 mcg/inh) inhalation powder is around $347 for a supply of 28 powder, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Trelegy Ellipta is available as a brand name drug only, a generic version is not yet available. View generic Trelegy Ellipta availability for more details.

Trelegy Ellipta prices

Inhalation Powder

100 mcg-62.5 mcg-25 mcg/inh

Trelegy Ellipta inhalation powder

 from $347.02

for 28 powder
Quantity Per unit Price
28 $12.39 $347.02
60 $12.22 $733.15

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

200 mcg-62.5 mcg-25 mcg/inh

Trelegy Ellipta inhalation powder

 from $347.02

for 28 powder
Quantity Per unit Price
28 $12.39 $347.02
60 $12.22 $733.15

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Trelegy Ellipta Coupons, Copay Cards and Rebates

Trelegy Ellipta offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.

Trelegy Ellipta Co-pay Coupon

Eligible commercially insured patients may pay $0 per 30/60/90-day supply (1-3 inhalers) with a maximum savings of up to $200 per month; offer valid for up to 12 uses; for additional information contact the program at 888-825-5249.

Applies to:
Trelegy Ellipta
Number of uses:
12 times
Expires
December 31, 2025

Form more information phone: 888-825-5249 or Visit website

Trelegy Ellipta Co-pay Coupon

Eligible commercially insured/RX not covered and uninsured patients may save up to $100 per 30-day prescription; offer valid for up to 12 uses.

Applies to:
Trelegy Ellipta
Number of uses:
12 times
Expires
December 31, 2025

Form more information phone: 888-825-5249 or Visit website

Healthcare provider may be able to order free samples of Trelegy Ellipta by visiting GSK Pro and creating an account or by calling 888-593-5977.

Applies to:
Trelegy Ellipta
Number of uses:
Contact the program

Form more information phone: 888-593-5977 or Visit website

Trelegy Ellipta Medicare Part D Extra Help Subsidy

Patients with Medicare Part D coverage may be eligible for the Extra Help Subsidy, which may lower premiums and prescription costs. Contact the program for more information.

Applies to:
Trelegy Ellipta
Number of uses:
Per prescription until program expires

Form more information phone: 800-772-1213 or Visit website

Patient Assistance & Copay Programs for Trelegy Ellipta

Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.

Provider: Patient Access Network Foundation (PAN)

Eligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Trelegy Ellipta (fluticasone furoate-umeclidinium-vilanterol) Powder; Inhalation

More information please phone: 866-316-7263 Visit Website

Provider: GSK Patient Assistance Program

Eligibility requirements:
  1. Must be uninsured
  2. At or below 300% of FPL
  3. Not required
  4. The patient must live in one of the 50 states, the District of Columbia, or Puerto Rico* and utilize the US healthcare system
  5. Patients may apply on their own or with the help of an advocate. Fax or mail enrollment documents to the program with patient name and date of birth on each page (faxed prescriptions are only valid if faxed directly from a prescriber's office). Eligible patients may receive 90 day supply of medicine to their home within 7 days of faxed enrollment (mailed enrollments may take longer to receive medicine). If enrollment documents are submitted by mail, submit ONLY COPIES of Proof of Household Income documents. Do not mail original income or tax documents. Documents submitted cannot be returned. *Puerto Rico Residents do not qualify for vaccine products.
Applicable drugs:
  • Trelegy Ellipta (fluticasone furoate-umeclidinium-vilanterol) Powder; Inhalation

More information please phone: 866-728-4368 Visit Website

Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.